1. Home
  2. CYCN vs MNDR Comparison

CYCN vs MNDR Comparison

Compare CYCN & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cyclerion Therapeutics Inc.

CYCN

Cyclerion Therapeutics Inc.

HOLD

Current Price

$1.66

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Logo Mobile-health Network Solutions Class A Ordinary Shares

MNDR

Mobile-health Network Solutions Class A Ordinary Shares

HOLD

Current Price

$1.77

Market Cap

6.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYCN
MNDR
Founded
2018
2016
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
6.6M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
CYCN
MNDR
Price
$1.66
$1.77
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.1M
9.9M
Earning Date
11-12-2025
10-31-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,855,000.00
$7,646,739.00
Revenue This Year
N/A
$608,852.40
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1371.65
N/A
52 Week Low
$1.28
$1.53
52 Week High
$9.47
$40.00

Technical Indicators

Market Signals
Indicator
CYCN
MNDR
Relative Strength Index (RSI) 51.46 44.51
Support Level $1.48 $1.85
Resistance Level $1.60 $2.92
Average True Range (ATR) 0.09 0.55
MACD 0.05 -0.05
Stochastic Oscillator 93.75 6.43

Price Performance

Historical Comparison
CYCN
MNDR

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.

Share on Social Networks: